Inspection classificationInspection ended August 24, 2026

FDA inspection of Carle Health Care Inc Reproductive Reproductive Windsor: NAI

No action indicated

FDA's record ↗

FDA classified an inspection of Carle Health Care Inc Reproductive Reproductive Windsor in Urbana, IL as NAI (no action indicated). The inspection ended on August 24, 2026. Product type: Biologics.

On the record

Establishment
Carle Health Care Inc Reproductive Reproductive Windsor
Location
Urbana, IL
Classification
NAI · No action indicated
Inspection ended
2026-08-24
Product type
Biologics
Fiscal year
FY2026
FDA establishment identifier (FEI)
3007093858
Source
FDA Data Dashboard ↗

The full record

An account shows the project areas inspected and whether citations were posted.

What an inspection classification is

After an inspection FDA classifies the outcome. NAI (no action indicated): no objectionable conditions were found, or none that justify further action. VAI (voluntary action indicated): objectionable conditions were found, but the agency is not prepared to take or recommend regulatory action. OAI (official action indicated): regulatory or administrative action is recommended.

More

Watch Carle Health Care Inc Reproductive Reproductive Windsor

A free account shows the last 7 days of every FDA, SEC and ClinicalTrials.gov source. Pro adds a watchlist: one email when FDA acts on a company you name.

From FDA Data Dashboard; FDA posts a classification after its review, which can be months after the inspection ended. The record may have changed since it was read.

Approve Suite is not affiliated with FDA, or with Carle Health Care Inc Reproductive Reproductive Windsor. Informational only.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.